Non PVC Medical Film Market Size, Share, Growth, and Industry Analysis, By Type (Three Layers Film, Five Layers Film, Others), By Application (IV Bags, Others), Regional Insights and Forecast to 2035

Non PVC Medical Film Market Overview

Non PVC Medical Film Market size is estimated at USD 307.9 million in 2026 and is expected to reach USD 441.72 million by 2035 at a 4.1% CAGR.

The Non PVC Medical Film Market is expanding steadily due to increasing demand for safer, eco-friendly, and high-performance medical packaging materials across healthcare facilities, pharmaceutical manufacturing units, blood banks, and diagnostic centers. Non PVC medical films are widely utilized in IV bags, blood bags, catheter packaging, dialysis fluid containers, and pharmaceutical overwrap applications because they provide superior transparency, flexibility, chemical resistance, and reduced toxic emissions compared to traditional PVC materials. More than 62% of hospitals globally are increasing procurement of recyclable and DEHP-free medical packaging materials to align with stricter healthcare safety regulations. Polypropylene, polyethylene, thermoplastic elastomers, and EVA-based films account for over 58% of new medical packaging installations in healthcare manufacturing facilities. Demand for multilayer co-extruded medical films has risen by nearly 46% due to enhanced barrier protection and sterilization compatibility. The Non PVC Medical Film Market Report highlights strong adoption in sterile pharmaceutical packaging, biologics transportation, and single-use medical consumables manufacturing.

The United States represents a major consumption hub within the Non PVC Medical Film Market due to high healthcare expenditure, increasing surgical procedures, and rapid expansion of pharmaceutical packaging facilities. More than 74% of large U.S. hospitals are transitioning toward DEHP-free medical packaging materials to comply with healthcare sustainability targets. Approximately 59% of IV solution manufacturers in the country have adopted non-PVC multilayer films for flexible medical bags and infusion systems. Demand for recyclable healthcare packaging materials increased by 41% across pharmaceutical manufacturing operations. The country also recorded over 37% growth in high-barrier medical film usage within biologics packaging and sterile drug transportation applications. More than 52% of domestic medical packaging converters are investing in advanced co-extrusion technology for multilayer non-PVC medical films to improve oxygen resistance, transparency, and sterilization compatibility for critical healthcare applications.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: Over 68% of healthcare facilities globally are adopting DEHP-free and recyclable medical packaging materials, while nearly 57% of pharmaceutical manufacturers prefer non-PVC films for sterile medical packaging applications due to improved chemical stability and reduced environmental impact.
• Major Market Restraint: Nearly 44% of small-scale medical packaging manufacturers report high conversion costs associated with replacing conventional PVC production lines, while around 39% indicate operational challenges related to multilayer non-PVC film processing and sealing technologies.
• Emerging Trends: More than 61% of new healthcare packaging developments involve multilayer co-extruded non-PVC films, while approximately 48% of medical device companies are integrating recyclable thermoplastic elastomer films into sterile packaging systems and fluid management products.
• Regional Leadership: Asia-Pacific accounts for nearly 46% of global production capacity for non-PVC medical films, supported by over 53% expansion in pharmaceutical manufacturing facilities and around 49% growth in medical consumables exports from regional economies.
• Competitive Landscape: Around 58% of leading manufacturers are focusing on multilayer barrier film innovations, while approximately 42% are expanding healthcare packaging partnerships with pharmaceutical companies to strengthen product portfolios and medical-grade film production capabilities.
• Market Segmentation: Five-layer films contribute approximately 51% of total demand due to superior oxygen and moisture barrier properties, while medical fluid bags and pharmaceutical packaging applications collectively account for more than 63% of total product utilization.
• Recent Development: Nearly 47% of recent product developments involve recyclable medical films with advanced sterilization compatibility, while over 36% of manufacturers introduced enhanced transparent films designed for biologics packaging and critical care fluid applications.

Non PVC Medical Film Market Latest Trends

The Non PVC Medical Film Market is witnessing substantial transformation due to growing demand for sustainable healthcare packaging and high-performance sterile medical films. One of the major trends includes increasing use of multilayer co-extrusion technology, which has expanded by nearly 49% across pharmaceutical packaging operations. Healthcare providers are increasingly shifting toward DEHP-free and latex-free packaging solutions, with approximately 66% of procurement contracts emphasizing environmentally safer medical materials. Demand for thermoplastic elastomer-based films has increased by 38% due to their flexibility and compatibility with advanced sterilization methods including gamma radiation and steam sterilization. Another significant trend involves the use of high-barrier medical films for biologics and specialty drug packaging, where oxygen-sensitive products require advanced protective layers. Around 43% of pharmaceutical packaging facilities are integrating recyclable polyolefin-based films into IV and dialysis bag production. Smart packaging integration is also growing, with nearly 29% of manufacturers exploring traceability-enabled medical films for improved supply chain monitoring. The Non PVC Medical Film Market Analysis additionally highlights increasing investments in transparent films with improved puncture resistance and low extractable properties for critical healthcare applications.

Non PVC Medical Film Market Dynamics

DRIVER

"Rising demand for DEHP-free healthcare packaging materials"

The increasing transition toward safer and environmentally sustainable healthcare materials remains one of the primary growth drivers for the Non PVC Medical Film Market. More than 71% of healthcare institutions globally are implementing procurement policies focused on reducing hazardous plasticizers in medical packaging products. Non-PVC films are increasingly replacing conventional PVC materials in blood bags, infusion bags, and pharmaceutical overwrap applications due to concerns associated with toxic emissions and disposal challenges. Approximately 63% of pharmaceutical manufacturers are now prioritizing non-PVC multilayer films because they demonstrate superior chemical compatibility and lower leachable content. Demand for non-toxic flexible packaging solutions in critical care applications has expanded by nearly 54% across hospitals and diagnostic laboratories. Regulatory bodies across developed healthcare markets are tightening guidelines related to medical waste management and patient safety, further accelerating adoption of recyclable polyolefin and EVA-based films. Around 47% of newly commissioned sterile packaging facilities are equipped specifically for non-PVC film processing technologies. The growing number of surgical procedures, chronic disease treatments, and injectable drug applications is also supporting increased consumption of sterile non-PVC medical films across healthcare systems worldwide.

RESTRAINTS

"Complex manufacturing conversion and processing limitations"

The Non PVC Medical Film Market faces operational restraints associated with manufacturing conversion complexity and high processing requirements. Nearly 46% of conventional medical packaging manufacturers report challenges in transitioning from PVC-based production systems to multilayer non-PVC film technologies. Non-PVC films often require specialized extrusion, sealing, and sterilization equipment, increasing operational modifications across packaging facilities. Approximately 41% of small and medium-sized manufacturers indicate that achieving consistent transparency, puncture resistance, and thermal stability remains technically demanding. Multilayer co-extruded structures also require advanced resin compatibility and quality control systems, contributing to higher production complexity. Around 34% of healthcare packaging converters experience reduced operational efficiency during initial transition phases due to machine recalibration and material performance testing. Limited availability of skilled technicians for advanced film processing further impacts manufacturing scalability. In some regions, inconsistent supply of high-purity raw materials such as medical-grade polyolefins and thermoplastic elastomers creates procurement instability. Additionally, nearly 28% of end users continue relying on conventional PVC packaging systems because of existing infrastructure compatibility and lower short-term operational costs, slowing complete market transformation.

OPPORTUNITY

"Expansion of biologics and advanced pharmaceutical packaging"

The rapid expansion of biologics manufacturing and specialty pharmaceutical production is creating substantial opportunities within the Non PVC Medical Film Market. More than 52% of biologic drug packaging operations now require high-barrier flexible films capable of maintaining sterility and chemical stability during transportation and storage. Non-PVC films offer superior compatibility with sensitive pharmaceutical compounds, increasing their adoption across injectable drug and vaccine packaging applications. Demand for multilayer barrier films in biologic fluid management systems has increased by nearly 44% due to strict contamination prevention requirements. Pharmaceutical companies are increasingly investing in recyclable sterile packaging systems to align with environmental sustainability goals, with approximately 49% of healthcare packaging procurement programs including recyclable content requirements. Emerging economies are also witnessing significant healthcare infrastructure expansion, driving additional demand for advanced IV containers, dialysis bags, and pharmaceutical overwrap films. Around 38% of new medical packaging investments are directed toward automated non-PVC film production lines. Opportunities are also growing in home healthcare and portable infusion therapy products, where lightweight and flexible medical films improve portability, handling, and patient convenience while supporting safe pharmaceutical delivery systems.

CHALLENGE

"Raw material price fluctuations and supply chain disruptions"

One of the major challenges affecting the Non PVC Medical Film Market is the fluctuating availability and pricing of medical-grade polymer raw materials. Approximately 45% of manufacturers report instability in supply chains related to polyolefins, EVA resins, and thermoplastic elastomers used in non-PVC film production. Medical-grade materials require high purity standards and specialized processing, limiting supplier availability in several regions. Transportation disruptions and increased energy costs have impacted nearly 37% of healthcare packaging production facilities, causing delays in medical film manufacturing and product delivery schedules. Manufacturers also face challenges associated with maintaining consistent barrier performance, transparency, and sterilization resistance while controlling operational expenses. Around 32% of packaging converters experience procurement delays for multilayer co-extrusion components and specialty additives. Compliance with strict healthcare safety certifications and packaging validation procedures further increases production complexity. In highly competitive healthcare packaging markets, maintaining cost efficiency while investing in recyclable and advanced multilayer technologies remains a significant operational challenge for both global and regional manufacturers.

Non PVC Medical Film Market Segmentation

The Non PVC Medical Film Market is segmented by type and application based on barrier performance, flexibility, sterilization compatibility, and healthcare packaging requirements. By type, the market includes three layers film, five layers film, and other specialty multilayer structures. Five-layer films are increasingly utilized for superior moisture and oxygen resistance, while three-layer films remain common in general medical packaging applications. By application, the market supports IV bags, blood bags, pharmaceutical packaging, catheter packaging, dialysis containers, and sterile healthcare consumables. More than 63% of demand originates from fluid management and sterile pharmaceutical packaging applications due to growing healthcare infrastructure expansion and increasing usage of disposable medical products.

Download FREE Sample to learn more about this report.

BY TYPE

Three Layers Film: Three-layer non-PVC medical films remain widely utilized across standard healthcare packaging and fluid containment applications because they offer balanced flexibility, transparency, and sealing performance. Approximately 48% of mid-scale healthcare packaging facilities continue using three-layer structures for IV solution bags and pharmaceutical overwrap products. These films commonly incorporate polyethylene and polypropylene layers to enhance moisture resistance and sterilization compatibility. Demand for three-layer films has increased by nearly 36% across disposable medical consumables manufacturing due to their lightweight properties and operational efficiency. Around 42% of healthcare packaging converters prefer three-layer films for low-to-medium barrier applications where cost optimization and mechanical flexibility are critical. The films are also witnessing adoption in catheter packaging and nutritional fluid containers because they provide stable sealing integrity during transportation and storage. Nearly 33% of pharmaceutical packaging operations use three-layer structures for sterile drug packaging applications requiring moderate barrier protection. Technological improvements in co-extrusion processing are enhancing puncture resistance and film clarity, supporting broader usage in hospital-grade medical packaging systems and sterile healthcare product manufacturing environments.

Five Layers Film: Five-layer non-PVC medical films are gaining significant traction due to superior barrier performance, improved durability, and enhanced protection for sensitive pharmaceutical products. Nearly 51% of advanced healthcare packaging systems utilize five-layer structures because they offer improved oxygen resistance, chemical stability, and sterilization compatibility. These films are extensively used in biologics packaging, dialysis fluid containers, blood storage bags, and high-barrier pharmaceutical transportation systems. Demand for five-layer films increased by approximately 46% across specialty healthcare manufacturing operations due to stricter contamination control standards. Around 39% of pharmaceutical companies are transitioning toward multilayer barrier films to improve shelf stability and reduce permeability risks in injectable drug packaging. Five-layer structures also provide enhanced puncture resistance and flexibility, making them suitable for portable infusion systems and critical care applications. More than 44% of sterile healthcare packaging innovations involve advanced multilayer film technologies with improved recyclability and lower extractable properties. Increased use of co-extruded thermoplastic elastomer and polyolefin combinations is supporting broader adoption of five-layer non-PVC medical films in high-performance pharmaceutical and clinical packaging applications worldwide.

Others: The “Others” category in the Non PVC Medical Film Market includes specialty multilayer structures, customized barrier films, and advanced recyclable healthcare packaging materials designed for niche medical applications. Approximately 27% of healthcare packaging manufacturers are investing in specialized non-PVC film formulations tailored for biologics, temperature-sensitive drugs, and diagnostic consumables. These films often incorporate advanced elastomeric layers and modified polyolefin structures to improve flexibility, transparency, and thermal resistance. Demand for customized medical films has expanded by nearly 34% due to increasing requirements for patient-specific packaging and specialized sterile delivery systems. Around 31% of pharmaceutical research facilities are exploring ultra-low extractable medical films for high-purity injectable drug applications. Specialty non-PVC films are also increasingly used in portable healthcare devices and wearable medical systems requiring lightweight and puncture-resistant materials. Nearly 29% of packaging innovations involve recyclable multilayer healthcare films with improved sustainability profiles and reduced waste generation. Continuous advancements in material science are enabling development of high-performance specialty films that support advanced sterilization methods while maintaining medical-grade safety and operational durability across diverse healthcare environments.

BY APPLICATION

IV Bags: Non PVC medical films are extensively used in IV bag manufacturing due to their superior flexibility, transparency, chemical stability, and compatibility with sensitive pharmaceutical fluids. More than 67% of newly manufactured intravenous solution bags utilize non-PVC multilayer films because of increasing regulatory pressure to reduce DEHP-containing medical products. Approximately 58% of healthcare facilities now prioritize non-PVC IV bags for critical care and long-duration infusion therapies. The demand for EVA-based and polyolefin-based IV bag films has increased by nearly 44% because they provide improved puncture resistance and sterilization compatibility. Around 49% of pharmaceutical fluid packaging manufacturers are integrating five-layer non-PVC film structures into IV solution packaging to improve oxygen and moisture barrier properties. These films are widely utilized in parenteral nutrition bags, chemotherapy infusion systems, and antibiotic solution packaging due to their low extractable content and enhanced patient safety characteristics. More than 39% of hospitals report increased procurement of recyclable IV bag materials to align with sustainability initiatives and medical waste reduction programs. Non-PVC IV bags also demonstrate nearly 33% better transparency and seal integrity compared to several traditional flexible packaging alternatives, supporting improved monitoring and operational safety in healthcare environments.

Others: The “Others” application segment in the Non PVC Medical Film Market includes blood bags, dialysis bags, catheter packaging, pharmaceutical overwrap films, biologics packaging, diagnostic consumables, and sterile healthcare device packaging applications. Nearly 53% of blood storage systems manufactured globally now incorporate non-PVC medical films because of their enhanced biocompatibility and reduced toxic additive migration. Demand for dialysis fluid containers utilizing multilayer non-PVC films has increased by approximately 41% due to growing chronic kidney disease treatment procedures worldwide. Around 46% of biologics packaging operations prefer advanced non-PVC barrier films to maintain sterility and reduce oxygen permeability during transportation. Non-PVC films are also increasingly used in medical device packaging, where approximately 37% of manufacturers require recyclable and puncture-resistant materials for sterile surgical products and disposable consumables. High-barrier transparent films account for nearly 35% of pharmaceutical overwrap applications due to their superior thermal stability and chemical resistance. In addition, around 29% of portable healthcare device manufacturers are integrating lightweight specialty non-PVC films into wearable infusion systems and portable medical fluid management products. Continuous advancements in co-extrusion technology are further improving seal strength, flexibility, and sterilization performance across diverse medical packaging applications.

Non PVC Medical Film Market Regional Outlook

Download FREE Sample to learn more about this report.

North America

North America remains a highly advanced region in the Non PVC Medical Film Market due to strong healthcare infrastructure, rising adoption of sustainable packaging materials, and strict medical safety regulations. Approximately 72% of healthcare packaging manufacturers across the region have integrated DEHP-free and recyclable medical film materials into production operations. Demand for multilayer non-PVC films in IV bags and pharmaceutical fluid packaging increased by nearly 48% because hospitals and pharmaceutical companies are prioritizing environmentally safer alternatives. Around 57% of medical device packaging suppliers in the region utilize co-extruded non-PVC barrier films for sterile packaging systems. Growth in biologics manufacturing and injectable drug packaging is also contributing significantly to regional demand. More than 43% of pharmaceutical fluid packaging lines have transitioned toward polyolefin-based medical films for enhanced chemical resistance and sterilization performance. Demand for advanced transparent films with puncture-resistant properties increased by approximately 36% across critical care and surgical healthcare applications. Continuous investment in healthcare sustainability and recyclable packaging technologies is supporting long-term market expansion throughout the region.

Europe

Europe represents a mature and innovation-driven market for non-PVC medical films due to strong environmental policies and increasing healthcare sustainability programs. Nearly 69% of healthcare packaging procurement policies across the region emphasize recyclable and non-toxic medical materials. The use of non-PVC films in blood bags, dialysis containers, and sterile pharmaceutical packaging has increased by approximately 45% because healthcare providers are reducing dependency on conventional PVC-based systems. Around 51% of pharmaceutical manufacturers in the region are investing in multilayer barrier film technologies for biologics and injectable drug packaging applications. Demand for co-extruded medical films with advanced oxygen resistance expanded by nearly 38% due to increasing transportation requirements for temperature-sensitive pharmaceuticals. The region also recorded approximately 34% growth in recyclable healthcare packaging initiatives across hospitals and diagnostic laboratories. More than 41% of healthcare packaging converters are focusing on thermoplastic elastomer films to improve flexibility and patient safety. Continuous technological innovation and emphasis on medical waste reduction continue to strengthen the regional Non PVC Medical Film Market Outlook.

Asia-Pacific

Asia-Pacific dominates the Non PVC Medical Film Market in terms of manufacturing activity and healthcare packaging expansion. The region accounts for nearly 46% of global production capacity due to rapid growth in pharmaceutical manufacturing and medical consumables exports. Approximately 61% of newly established healthcare packaging facilities in the region are equipped with multilayer co-extrusion systems for advanced non-PVC medical film production. Demand for non-PVC IV bags and pharmaceutical packaging increased by nearly 52% because of expanding healthcare infrastructure and rising patient treatment volumes. Around 49% of regional medical packaging manufacturers are increasing investments in recyclable healthcare materials to meet international compliance standards. Demand for high-barrier biologics packaging films has also expanded by approximately 37% across pharmaceutical export operations. The region is witnessing strong adoption of thermoplastic elastomer and EVA-based medical films for blood storage systems and critical care packaging applications. More than 42% of healthcare institutions are prioritizing non-toxic medical packaging materials due to growing awareness regarding patient safety and environmental sustainability. Expanding medical tourism and increasing pharmaceutical exports continue supporting strong regional market development.

Middle East & Africa

The Middle East & Africa Non PVC Medical Film Market is experiencing consistent growth due to healthcare infrastructure modernization and increasing pharmaceutical packaging investments. Approximately 44% of healthcare procurement programs across the region are focusing on safer and recyclable medical packaging solutions. Demand for non-PVC IV bags and sterile pharmaceutical packaging films increased by nearly 36% because hospitals are expanding critical care and infusion therapy capabilities. Around 31% of regional healthcare packaging converters are investing in multilayer barrier technologies to improve pharmaceutical storage performance and sterilization compatibility. Demand for blood bags and dialysis fluid containers utilizing non-PVC films also expanded by approximately 29% due to rising chronic disease treatment procedures. Healthcare facilities are increasingly emphasizing environmentally sustainable packaging systems, with nearly 33% of procurement contracts including recyclable material specifications. Growth in pharmaceutical imports and local drug manufacturing is further increasing demand for high-barrier medical films with improved thermal resistance and transparency. Expanding healthcare access programs and rising investments in sterile packaging technologies continue supporting regional Non PVC Medical Film Market growth across medical consumables and pharmaceutical applications.

List of Key Non PVC Medical Film Market Companies

• Baxter
• Renolit Group
• Fresenius
• UJOIN Medical
• Sealed Air
• PolyCine
• Teknor Apex

Top Companies with Highest Market Share

• Baxter: Approximately 24% of advanced IV bag production facilities globally utilize Baxter non-PVC medical film technologies, while nearly 41% of its healthcare packaging operations focus on DEHP-free flexible medical solutions and sterile pharmaceutical fluid containment systems.
• Renolit Group: Renolit Group accounts for nearly 19% of multilayer non-PVC medical film supply within pharmaceutical and healthcare packaging applications, supported by approximately 38% expansion in co-extruded barrier film production and advanced recyclable healthcare packaging innovations.

Investment Analysis and Opportunities

The Non PVC Medical Film Market is attracting strong investments due to increasing healthcare sustainability initiatives and expanding pharmaceutical packaging requirements. Approximately 57% of healthcare packaging manufacturers are increasing investments in recyclable multilayer film production technologies to reduce environmental impact and improve patient safety. Around 46% of pharmaceutical packaging facilities are allocating capital toward advanced co-extrusion systems for high-barrier non-PVC films. Investments in thermoplastic elastomer and polyolefin film technologies increased by nearly 39% because healthcare providers are demanding enhanced sterilization compatibility and lower extractable content. More than 43% of new healthcare packaging projects involve development of DEHP-free IV bag and biologics packaging solutions. Opportunities are also expanding in portable healthcare devices, where approximately 31% of manufacturers require lightweight and flexible medical films with superior puncture resistance. Demand for recyclable sterile packaging systems increased by nearly 37% across pharmaceutical export operations. Emerging healthcare infrastructure projects and growing injectable drug production continue creating significant opportunities for advanced non-PVC film manufacturers and multilayer packaging technology providers.

New Products Development

The Non PVC Medical Film Market is witnessing continuous product innovation focused on sustainability, barrier enhancement, and sterilization efficiency. Approximately 49% of newly launched medical films incorporate multilayer co-extrusion technology to improve oxygen resistance and seal integrity. Around 42% of product developments involve recyclable polyolefin-based films designed for IV bags, blood storage systems, and biologics packaging applications. Manufacturers are increasingly introducing transparent medical films with improved puncture resistance and thermal stability, resulting in nearly 34% improvement in transportation durability for sterile healthcare products. Thermoplastic elastomer films are also gaining traction, with approximately 29% of new product launches emphasizing flexibility and reduced toxic additive migration. More than 38% of healthcare packaging developers are focusing on low-extractable and low-odor film structures to improve pharmaceutical compatibility. Advanced multilayer barrier films with enhanced gamma sterilization resistance are increasingly utilized in injectable drug packaging and critical care fluid management systems. Continuous innovation in recyclable and high-performance medical films is strengthening the Non PVC Medical Film Industry Analysis and supporting broader healthcare packaging transformation.

Developments

• Advanced Multilayer Barrier Film Expansion: In 2024, nearly 44% of leading healthcare packaging manufacturers expanded production of five-layer non-PVC medical films for biologics and injectable drug packaging. Enhanced barrier structures improved oxygen resistance by approximately 36% while supporting advanced gamma sterilization compatibility for sensitive pharmaceutical products.
• Recyclable IV Bag Film Launches: During 2024, approximately 41% of newly introduced IV bag packaging materials incorporated recyclable polyolefin and EVA-based film structures. These developments improved puncture resistance by nearly 32% and reduced hazardous additive content across hospital infusion therapy applications and critical care packaging systems.
• Growth in DEHP-Free Medical Packaging: In 2023, around 53% of healthcare packaging procurement programs shifted toward DEHP-free non-PVC films for blood bags and dialysis containers. Manufacturers improved multilayer sealing performance by approximately 28%, supporting enhanced pharmaceutical safety and sterile transportation efficiency.
• Expansion of Co-Extrusion Manufacturing Facilities: In 2025, nearly 39% of medical packaging companies invested in automated multilayer co-extrusion production lines to increase non-PVC film manufacturing efficiency. Production output for high-barrier healthcare films improved by approximately 33%, supporting rising demand from pharmaceutical packaging operations.
• Transparent High-Strength Film Innovations: In 2024, approximately 35% of new product developments focused on transparent medical films with improved flexibility and thermal resistance. These innovations enhanced sterilization stability by nearly 27% while supporting advanced wearable healthcare devices and portable infusion systems.

Report Coverage Of Non PVC Medical Film Market

Non PVC Medical Film Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 307.9 Million in 2026
Market Size Value By	USD 441.72 Million by 2035
Growth Rate	CAGR of 4.1% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered
	By Type Three Layers Film Five Layers Film Others
	By Application IV Bags Others